Trial Profile
A Proof-of-Concept Study to evaluate the benefit from add-on therapy with montelukast versus salmeterol in children with asthma carrying the Arg/Arg-16 beta2-receptor genotype
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2017
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary) ; Montelukast (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Proof of concept; Therapeutic Use
- 23 Mar 2017 New trial record